Low risk to public health in the EU from low pathogenic avian influenza A(H7N7) viruses
ECDC assesses the epidemiological and virological information about human infections with low pathogenic avian influenza A(H7N7) viruses, in response to an outbreak on a poultry farm in the United Kingdom in February 2015.
On 2 February 2015, British authorities reported an outbreak of low pathogenic avian influenza virus A(H7N7) on a chicken farm in Hampshire in the United Kingdom. Culling of the birds in the affected holding has started, with restriction and surveillance zones established, and investigations into how the birds became infected have been initiated.
Three persons who had been exposed to the flock reported an influenza-like illness or conjunctivitis, however no human infections with A(H7N7) or other respiratory viruses were identified.
Groups at risk for infection include people with occupational exposure to infected poultry, e.g. during the culling and destruction process when there are outbreaks on poultry farms. However, the risk for zoonotic transmission to the general public in EU/EEA countries is considered to be extremely low.
Outbreaks in poultry holdings caused by low pathogenic avian influenza A(H7N7) viruses have been reported previously in Europe, causing infections in humans occupationally exposed to infected poultry . Such infections caused mild disease with influenza-like symptoms or conjunctivitis.
Rapid Risk Assessment: Human infection by low pathogenic avian influenza A(H7) viruses, 13 February 2015
This rapid risk assessment summarises the epidemiological and virological information about human infections with low pathogenic avian influenza A(H7N7) viruses and assesses the risk to public health in the EU/EEA, in response to this outbreak.Read more
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.Read more
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.Read more
Epidemiological update: Review of influenza season 2016–2017 in the EU/EEA
The influenza season 2016–2017 has now come to an end in Europe. In week 17/2017, all EU/EEA countries reported low influenza activity and the positivity rate (proportion of influenza virus positives among all tested specimens) falling below the 10% benchmark to 9.9%. For the previous six weeks, almost all EU/EEA countries had reported low influenza activity.Read more